CREB-mediated activation of neuroplasticity and neuroprotection have implications for the development of neuroprotective strategies for numerous neurodegenerative disorders, including Alzheimer’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease [53]. The gene discussed is CREB1; the disease is amyotrophic lateral sclerosis.